Umeclidinium bromide/vilanterol
Umeclidinium bromide/vilanterol
Umeclidinium bromide/vilanterol (pronounced as yoo-mek-li-DIN-ee-um BROE-mide/vil-AN-ter-ol) is a combination medication used in the management of chronic obstructive pulmonary disease (COPD) including emphysema and chronic bronchitis.
Etymology
The name "Umeclidinium bromide" is derived from its chemical structure, which includes a quaternary ammonium cation (umeclidinium) and a bromide anion. "Vilanterol" is a name given by the pharmaceutical company that developed it, and does not have a specific etymological origin.
Usage
Umeclidinium bromide/vilanterol is used as a long-acting bronchodilator. The umeclidinium bromide component is a muscarinic antagonist, which works by relaxing the muscles in the airways to improve breathing. Vilanterol is a long-acting beta2-adrenergic agonist (LABA) that works by opening airways in the lungs to make breathing easier.
Related Terms
- Bronchodilator
- Muscarinic antagonist
- Long-acting beta2-adrenergic agonist
- Chronic obstructive pulmonary disease
- Emphysema
- Chronic bronchitis
Side Effects
Common side effects of umeclidinium bromide/vilanterol may include upper respiratory tract infection, stuffy or runny nose, cough, sore throat, and headache. Serious side effects may include worsening breathing problems, signs of a serious allergic reaction (such as rash, itching/swelling, severe dizziness, trouble breathing), or signs of high blood pressure (such as severe headache, pounding in the neck/ears, irregular heartbeat).
Precautions
Before using umeclidinium bromide/vilanterol, inform your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems.
External links
- Medical encyclopedia article on Umeclidinium bromide/vilanterol
- Wikipedia's article - Umeclidinium bromide/vilanterol
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski